KM Research Hub
← 返回结果库查看论文详情PubMed ↗
READ-ONLY DIGITIZATION RESULT

Negative hyperselection of patients with stage III colon cancer receiving anti-EGFR-based adjuvant treatment.

ESMO Open · 2025-Nov · PMID 41167084

Panel C质量警告待 EXE 对齐验证

relapse-free survival

Figure 4 Kaplan–Meier curves for relapse-free survival (RFS) and overall survival (OS) according to molecular profile and treatment arm in patients with distal or proximal primary tumor location. (A and B) display Kaplan–Meier curves for RFS and OS in patients with hyperselected or gene altered distal colon cancer treated with FOLFOX or FOLFOX + cetuximab; (C and D) display Kaplan–Meier curves for RFS and OS in patients with hyperselected or gene altered proximal colon cancer treated with FOLFOX or FOLFOX + cetuximab. CI, confidence interval; GA, gene altered; HR, hazard ratio; HS, hyperselected.

算法:legacy-0.5.0引擎:enhanced-linux
质量评分0.72
质量通过否
预期曲线4
实际曲线3
X 范围-
Y 范围-

曲线数据

网页最多预览 200 行,完整数据请下载 CSV 或 JSON。

当前面板没有可预览的 `curves_mapped.csv` 数据。
历史版本(1)

重跑只新增版本,不覆盖旧结果;正式可用状态仅授予通过 EXE 基准或人工复核的版本。

版本状态验证曲线时间
legacy-0.5.0quality_warning待验证32026-07-23T17:13:48+00:00